# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-129723
Filing Date
2019-04-30
Accepted
2019-04-30 17:14:04
Documents
4
Period of Report
2019-06-26
Effectiveness Date
2019-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d664711ddef14a.htm | DEF 14A | 897604
2 | GRAPHIC | g664711dsp001.jpg | GRAPHIC | 293750
3 | GRAPHIC | g664711dsp002.jpg | GRAPHIC | 187254
4 | GRAPHIC | g664711g16y78.jpg | GRAPHIC | 28370
| Complete submission text file | 0001193125-19-129723.txt |  | 1600488

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50768 | Film No.: 19783120
SIC: 2834 Pharmaceutical Preparations